| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Myocarditis | 28 | 2021 | 2731 | 2.10 | Why? |
| Coxsackievirus Infections | 8 | 2020 | 71 | 1.13 | Why? |
| Myocardium | 18 | 2021 | 2323 | 1.03 | Why? |
| Cardiomyopathy, Dilated | 7 | 2020 | 251 | 0.82 | Why? |
| Ventricular Remodeling | 3 | 2020 | 349 | 0.75 | Why? |
| Enterovirus B, Human | 5 | 2019 | 124 | 0.72 | Why? |
| Biopsy | 17 | 2021 | 2811 | 0.63 | Why? |
| Cardiomyopathies | 8 | 2020 | 997 | 0.58 | Why? |
| Magnetic Resonance Imaging, Cine | 5 | 2018 | 669 | 0.51 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.51 | Why? |
| Myocytes, Cardiac | 5 | 2020 | 804 | 0.43 | Why? |
| Endocardium | 3 | 2021 | 90 | 0.42 | Why? |
| Magnetic Resonance Imaging | 5 | 2021 | 6551 | 0.36 | Why? |
| Methamphetamine | 2 | 2017 | 82 | 0.32 | Why? |
| Enterovirus | 3 | 2018 | 402 | 0.30 | Why? |
| Sarcoidosis | 2 | 2018 | 271 | 0.27 | Why? |
| Biology | 1 | 2021 | 71 | 0.21 | Why? |
| Ventricular Function, Left | 3 | 2018 | 1555 | 0.21 | Why? |
| Estradiol | 1 | 2021 | 250 | 0.20 | Why? |
| Polydeoxyribonucleotides | 1 | 2020 | 118 | 0.20 | Why? |
| Mitochondrial Dynamics | 1 | 2019 | 30 | 0.20 | Why? |
| Heart Failure | 7 | 2020 | 6638 | 0.19 | Why? |
| Macrophage Colony-Stimulating Factor | 1 | 2018 | 30 | 0.19 | Why? |
| Receptors, Complement | 1 | 2018 | 15 | 0.19 | Why? |
| GTP Phosphohydrolases | 1 | 2019 | 89 | 0.19 | Why? |
| Tachycardia | 2 | 2017 | 239 | 0.19 | Why? |
| Lymphocyte Antigen 96 | 1 | 2018 | 16 | 0.19 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 8843 | 0.19 | Why? |
| Oncolytic Viruses | 1 | 2018 | 20 | 0.19 | Why? |
| Microvascular Angina | 1 | 2018 | 19 | 0.19 | Why? |
| Acyltransferases | 1 | 2018 | 61 | 0.18 | Why? |
| Acetylcholine | 1 | 2018 | 53 | 0.18 | Why? |
| Coronary Vasospasm | 1 | 2018 | 36 | 0.18 | Why? |
| Mitochondrial Proteins | 1 | 2019 | 152 | 0.18 | Why? |
| TNF Receptor-Associated Factor 6 | 1 | 2017 | 20 | 0.18 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.18 | Why? |
| Pneumonia, Staphylococcal | 1 | 2017 | 38 | 0.18 | Why? |
| Graft Survival | 2 | 2019 | 587 | 0.18 | Why? |
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 35 | 0.18 | Why? |
| Cardiomyopathy, Restrictive | 1 | 2017 | 30 | 0.18 | Why? |
| Graft Rejection | 2 | 2019 | 1766 | 0.17 | Why? |
| Amphetamine-Related Disorders | 1 | 2017 | 31 | 0.17 | Why? |
| Aminopyridines | 1 | 2018 | 121 | 0.17 | Why? |
| Heart Diseases | 3 | 2020 | 3503 | 0.17 | Why? |
| Mice | 10 | 2019 | 21357 | 0.17 | Why? |
| Proteasome Inhibitors | 1 | 2018 | 127 | 0.17 | Why? |
| Interferon Regulatory Factors | 1 | 2018 | 141 | 0.17 | Why? |
| Parvovirus B19, Human | 1 | 2017 | 73 | 0.17 | Why? |
| Troponin | 2 | 2021 | 1058 | 0.17 | Why? |
| Echocardiography, Three-Dimensional | 1 | 2018 | 135 | 0.16 | Why? |
| Receptors, IgG | 1 | 2021 | 578 | 0.16 | Why? |
| RNA, Small Interfering | 2 | 2018 | 817 | 0.16 | Why? |
| Mitochondrial Membrane Transport Proteins | 1 | 2019 | 239 | 0.16 | Why? |
| Gadolinium | 1 | 2017 | 318 | 0.16 | Why? |
| Heparitin Sulfate | 1 | 2018 | 285 | 0.16 | Why? |
| Galectin 3 | 1 | 2017 | 76 | 0.16 | Why? |
| Lupus Erythematosus, Systemic | 2 | 2018 | 1380 | 0.16 | Why? |
| Amyloidosis | 1 | 2018 | 178 | 0.16 | Why? |
| Bacterial Toxins | 1 | 2017 | 185 | 0.15 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.15 | Why? |
| Animals | 18 | 2021 | 78931 | 0.15 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.15 | Why? |
| Ventricular Dysfunction | 1 | 2017 | 150 | 0.15 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2017 | 249 | 0.15 | Why? |
| Cyclosporine | 1 | 2019 | 449 | 0.15 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2017 | 193 | 0.15 | Why? |
| Education | 1 | 2020 | 434 | 0.15 | Why? |
| Parvoviridae Infections | 1 | 2017 | 222 | 0.15 | Why? |
| Tachycardia, Ventricular | 1 | 2018 | 251 | 0.14 | Why? |
| Virus Assembly | 1 | 2018 | 438 | 0.14 | Why? |
| Toll-Like Receptors | 1 | 2018 | 365 | 0.14 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.14 | Why? |
| Chronic Disease | 3 | 2019 | 5139 | 0.14 | Why? |
| Mitochondria | 2 | 2019 | 857 | 0.14 | Why? |
| Disease Models, Animal | 9 | 2020 | 10998 | 0.14 | Why? |
| Cardiac Imaging Techniques | 1 | 2017 | 357 | 0.14 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.14 | Why? |
| Autoimmune Diseases | 2 | 2018 | 1996 | 0.13 | Why? |
| Oligopeptides | 1 | 2018 | 576 | 0.13 | Why? |
| Stroke Volume | 3 | 2018 | 2153 | 0.13 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.12 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.12 | Why? |
| Troponin T | 1 | 2018 | 771 | 0.12 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.12 | Why? |
| Heart-Assist Devices | 1 | 2020 | 812 | 0.12 | Why? |
| Heart Ventricles | 2 | 2017 | 1139 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| Inflammation | 5 | 2020 | 13255 | 0.11 | Why? |
| Defibrillators, Implantable | 1 | 2018 | 624 | 0.11 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 711 | 0.11 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.11 | Why? |
| Immunohistochemistry | 4 | 2021 | 2275 | 0.11 | Why? |
| RNA | 1 | 2018 | 1278 | 0.11 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.11 | Why? |
| Heart Transplantation | 2 | 2018 | 1293 | 0.10 | Why? |
| Apoptosis | 1 | 2020 | 2335 | 0.10 | Why? |
| Acute Disease | 3 | 2018 | 6029 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.10 | Why? |
| RNA, Messenger | 3 | 2019 | 5131 | 0.10 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.10 | Why? |
| Killer Cells, Natural | 1 | 2019 | 2093 | 0.10 | Why? |
| Fibrosis | 3 | 2017 | 800 | 0.09 | Why? |
| Gene Expression Regulation | 2 | 2019 | 4020 | 0.09 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2018 | 1047 | 0.09 | Why? |
| Myocardial Infarction | 2 | 2019 | 3361 | 0.09 | Why? |
| Mice, Knockout | 3 | 2017 | 1815 | 0.09 | Why? |
| Mice, Inbred BALB C | 4 | 2019 | 5814 | 0.09 | Why? |
| Male | 28 | 2021 | 367725 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.08 | Why? |
| Aquaporin 4 | 1 | 2007 | 69 | 0.08 | Why? |
| Humans | 44 | 2021 | 930598 | 0.08 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.08 | Why? |
| Coronary Artery Disease | 1 | 2021 | 2570 | 0.08 | Why? |
| Transplantation, Homologous | 2 | 2019 | 757 | 0.07 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.07 | Why? |
| Signal Transduction | 2 | 2020 | 7207 | 0.07 | Why? |
| Female | 24 | 2021 | 380317 | 0.07 | Why? |
| Lymphocytes | 1 | 2018 | 3056 | 0.07 | Why? |
| Interferon-gamma | 3 | 2021 | 2711 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.07 | Why? |
| HeLa Cells | 2 | 2018 | 1303 | 0.07 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.07 | Why? |
| Adult | 16 | 2021 | 244371 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Cells, Cultured | 3 | 2018 | 5835 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2021 | 253789 | 0.06 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.06 | Why? |
| Predictive Value of Tests | 4 | 2018 | 9537 | 0.06 | Why? |
| Echovirus Infections | 1 | 2020 | 23 | 0.06 | Why? |
| Heart | 3 | 2018 | 1791 | 0.06 | Why? |
| Postoperative Complications | 2 | 2017 | 5861 | 0.06 | Why? |
| Erythema Infectiosum | 1 | 2020 | 31 | 0.06 | Why? |
| Echocardiography | 3 | 2021 | 3661 | 0.05 | Why? |
| Hypogonadism | 1 | 2021 | 196 | 0.05 | Why? |
| Biomarkers | 6 | 2020 | 23361 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Peptide Elongation Factors | 1 | 2019 | 3 | 0.05 | Why? |
| Cathepsins | 1 | 2020 | 204 | 0.05 | Why? |
| Mice, Transgenic | 2 | 2017 | 2739 | 0.05 | Why? |
| Dynamins | 1 | 2019 | 19 | 0.05 | Why? |
| GPI-Linked Proteins | 1 | 2021 | 317 | 0.05 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.05 | Why? |
| Electrocardiography | 3 | 2018 | 3957 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.05 | Why? |
| Roseolovirus Infections | 1 | 2020 | 131 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2019 | 5397 | 0.05 | Why? |
| CD55 Antigens | 1 | 2018 | 14 | 0.05 | Why? |
| Diagnosis, Differential | 3 | 2018 | 7220 | 0.05 | Why? |
| Blood Coagulation Factors | 1 | 2020 | 223 | 0.05 | Why? |
| Heart Rate | 2 | 2019 | 1527 | 0.05 | Why? |
| Virus Replication | 2 | 2017 | 14331 | 0.05 | Why? |
| Protein Kinases | 1 | 2019 | 93 | 0.05 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.05 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.05 | Why? |
| Intracellular Space | 1 | 2018 | 60 | 0.05 | Why? |
| Prosthesis Implantation | 1 | 2020 | 261 | 0.04 | Why? |
| Patch-Clamp Techniques | 1 | 2017 | 49 | 0.04 | Why? |
| Amyloid Neuropathies, Familial | 1 | 2018 | 77 | 0.04 | Why? |
| Membrane Potentials | 1 | 2017 | 56 | 0.04 | Why? |
| Coronary Angiography | 2 | 2018 | 2275 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Microtubule-Associated Proteins | 1 | 2019 | 187 | 0.04 | Why? |
| Electrophysiological Phenomena | 1 | 2017 | 59 | 0.04 | Why? |
| Gene Silencing | 1 | 2018 | 213 | 0.04 | Why? |
| Cardiomegaly | 1 | 2018 | 96 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| Radiographic Image Enhancement | 1 | 2017 | 89 | 0.04 | Why? |
| Radionuclide Imaging | 1 | 2018 | 184 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Cardiac Output | 1 | 2018 | 183 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Tissue Culture Techniques | 1 | 2017 | 158 | 0.04 | Why? |
| Biopsy, Needle | 1 | 2017 | 303 | 0.04 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.04 | Why? |
| Cytotoxicity, Immunologic | 1 | 2018 | 287 | 0.04 | Why? |
| Epstein-Barr Virus Infections | 1 | 2020 | 366 | 0.04 | Why? |
| Galectins | 1 | 2017 | 109 | 0.04 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.04 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.04 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.04 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.04 | Why? |
| Vasodilator Agents | 1 | 2018 | 344 | 0.04 | Why? |
| Abdominal Pain | 1 | 2020 | 858 | 0.03 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.03 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2020 | 1136 | 0.03 | Why? |
| Arrhythmias, Cardiac | 2 | 2019 | 2510 | 0.03 | Why? |
| Sex Distribution | 1 | 2021 | 2083 | 0.03 | Why? |
| Autoantigens | 1 | 2017 | 388 | 0.03 | Why? |
| Germany | 2 | 2021 | 9196 | 0.03 | Why? |
| Cytomegalovirus Infections | 1 | 2020 | 667 | 0.03 | Why? |
| Organ Specificity | 1 | 2018 | 1070 | 0.03 | Why? |
| Antigen Presentation | 1 | 2017 | 524 | 0.03 | Why? |
| Rare Diseases | 1 | 2017 | 373 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.03 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.03 | Why? |
| Autoimmunity | 1 | 2020 | 841 | 0.03 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Viral Tropism | 1 | 2020 | 1329 | 0.03 | Why? |
| Cardiology | 2 | 2017 | 2873 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.03 | Why? |
| Ventricular Dysfunction, Left | 1 | 2020 | 993 | 0.03 | Why? |
| Pericarditis | 1 | 2017 | 417 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 5002 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.03 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| False Negative Reactions | 1 | 2017 | 1785 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Virion | 1 | 2018 | 1444 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.02 | Why? |
| Hepatitis C | 1 | 2020 | 1514 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.02 | Why? |
| Proteome | 1 | 2018 | 1812 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Aftercare | 1 | 2017 | 1637 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.02 | Why? |
| Feasibility Studies | 1 | 2016 | 3467 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Immunologic Memory | 1 | 2018 | 3362 | 0.02 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Edema | 1 | 2007 | 333 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2019 | 5837 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Receptors, Virus | 1 | 2018 | 5659 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Up-Regulation | 1 | 2007 | 2249 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Ischemia | 1 | 2007 | 901 | 0.01 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Ultrasonography | 1 | 2007 | 4409 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |